Origins of MCL genes
Tier 1 MCL genes
| Gene | Status | First MCL study | Other lists |
|---|---|---|---|
| ATM | MCL Tier 1 | Bea et al | DLBCL, MZL |
| BIRC3 | MCL Tier 1 | Bea et al | DLBCL, MZL, PMBL |
| CARD11 | MCL Tier 1 | Wu et al | DLBCL, MZL, FL, BL |
| CCND1 | MCL Tier 1 | Bea et al | |
| DAZAP1 | MCL Tier 1 | Pararajalingam et al | DLBCL |
| EWSR1 | MCL Tier 1 | Pararajalingam et al | PMBL |
| HNRNPH1 | MCL Tier 1 | Pararajalingam et al | DLBCL |
| KMT2D | MCL Tier 1 | Bea et al | FL, BL, DLBCL, PMBL, MZL |
| MEF2B | MCL Tier 1 | Bea et al | FL, DLBCL |
| NFKBIE | MCL Tier 1 | Pararajalingam et al | DLBCL, PMBL |
| NOTCH1 | MCL Tier 1 | Bea et al | MZL, DLBCL, BL |
| NOTCH2 | MCL Tier 1 | Bea et al | MZL, DLBCL |
| NSD2 | MCL Tier 1 | Bea et al | DLBCL |
| POT1 | MCL Tier 1 | Zhang et al | |
| RB1 | MCL Tier 1 | Zhang et al | DLBCL |
| S1PR1 | MCL Tier 1 | Pararajalingam et al | DLBCL |
| SMARCA4 | MCL Tier 1 | Nadeu et al | DLBCL, BL, FL, PMBL |
| SP140 | MCL Tier 1 | Bea et al | |
| SYNE1 | MCL Tier 1 | Nadeu et al | |
| TERT | MCL Tier 1 | Nadeu et al | |
| TLR2 | MCL Tier 1 | Bea et al | DLBCL |
| TP53 | MCL Tier 1 | Bea et al | PMBL, DLBCL, FL, BL, MZL |
| UBR5 | MCL Tier 1 | Pararajalingam et al | DLBCL |
Tier 2 MCL genes
References
1.
Sarkozy C, Hung SS, Chavez EA, Duns G, Takata
K, Chong LC, Aoki T, Jiang A, Miyata-Takata T, Telenius A, Slack GW,
Molina TJ, Ben-Neriah S, Farinha P, Dartigues P, Damotte D, Mottok A,
Salles GA, Casasnovas RO, Savage KJ, Laurent C, Scott DW,
Traverse-Glehen A, Steidl C. Mutational landscape of
gray zone lymphoma. Blood. 2021 Apr 1;137(13):1765–1776.
2.
Zhang J, Grubor V, Love CL, Banerjee A,
Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G,
Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C,
Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A,
Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J,
Chadburn A, Levy S, Dunson D, Dave SS. Genetic heterogeneity of diffuse
large B-cell lymphoma. Proceedings of the
National Academy of Sciences of the United States of America.
2013;110:1398–1403. PMCID: PMC3557051
3.
Zhou
P, Blain AE, Newman AM, Zaka M, Chagaluka G, Adlar FR, Offor UT,
Broadbent C, Chaytor L, Whitehead A, Hall A, O’Connor H, Van Noorden S,
Lampert I, Bailey S, Molyneux E, Bacon CM, Bomken S, Rand V. Sporadic
and endemic Burkitt lymphoma have frequent
FOXO1 mutations but distinct hotspots in the
AKT recognition motif. Blood Adv. 2019 Jul
23;3(14):2118–2127. PMCID: PMC6650741
4.
Spina V, Khiabanian H, Messina M, Monti S,
Cascione L, Bruscaggin A, Spaccarotella E, Holmes AB, Arcaini L, Lucioni
M, Tabbò F, Zairis S, Diop F, Cerri M, Chiaretti S, Marasca R, Ponzoni
M, Deaglio S, Ramponi A, Tiacci E, Pasqualucci L, Paulli M, Falini B,
Inghirami G, Bertoni F, Foà R, Rabadan R, Gaidano G, Rossi D. The
genetics of nodal marginal zone lymphoma. Blood. 2016 Sep
8;128(10):1362–1373. PMCID: PMC5016706


